triazoles has been researched along with terbinafine in 122 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (4.10) | 18.7374 |
1990's | 8 (6.56) | 18.2507 |
2000's | 46 (37.70) | 29.6817 |
2010's | 52 (42.62) | 24.3611 |
2020's | 11 (9.02) | 2.80 |
Authors | Studies |
---|---|
Yamaguchi, H | 1 |
Graybill, JR; Sharkey, PK | 1 |
Aguirre, T; Lazardi, K; Piras, MM; Piras, R; Urbina, JA | 1 |
de Souza, W; Lazardi, K; Urbina, JA | 1 |
Hay, RJ | 1 |
Stevens, DA | 1 |
Bennett, JE; Kan, VL | 1 |
Cauwenbergh, G | 1 |
Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
Hiratani, T; Yamaguchi, H | 1 |
Maldonado, RA; Molina, J; Payares, G; Urbina, JA | 1 |
Chiritescu, ME; Chiritescu, MM; Scher, RK | 1 |
Dagger, F; Hernandez, A; Liendo, A; Rangel, H; Urbina, JA | 1 |
Müller, FM; Weig, M | 1 |
Leitner, I; Ryder, NS | 1 |
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
Kakehi, K; Senda, H; Tatsumi, Y; Yokoo, M | 1 |
Meis, JF; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA | 1 |
Ellis, DH; Gosbell, IB; Kuo, RS; Perrie, RC; Toumasatos, V; Yong, J | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL | 1 |
Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR | 1 |
Gil-Lamaignere, C; Müller, FM; Zhu, LP | 1 |
Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E | 1 |
Ausma, J; Backx, LJ; Borgers, M; Corens, D; De Groot, A; Heeres, J; Marichal, PJ; Meerpoel, L; Odds, FC; Oris, M; Van Breda, A; Van der Veken, LJ; van Dorsselaer, P; Van Gerven, F; Vanden Bossche, HF; Vermuyten, KJ; Willemsens, GH; Woestenborghs, FA | 1 |
Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Viudes, A | 1 |
Ji, HT; Miao, ZY; Sheng, CQ; Song, YL; Yang, S; Yao, JZ; Yu, JX; Zhang, M; Zhang, WN; Zhu, J | 1 |
Irving, H; Labrom, R; Nissen, M; O'Regan, P; Siebert, D; Whyte, M | 1 |
Batra, R; Gupta, AK; Kohli, Y | 1 |
McCluskey, P; Singh, RP | 1 |
Alvarado, P; de Albornoz, MC; Díaz de Torres, E; Lucena, L; Mendoza, M | 1 |
Chamilos, G; Kontoyiannis, DP | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Laine, K; Leino, K; Neuvonen, PJ; Olkkola, KT; Saari, TI; Valtonen, M | 1 |
Bhat, SV; Paterson, DL; Rinaldi, MG; Veldkamp, PJ | 1 |
Coates, PT; Grove, DI; Li, JY; Yong, TY | 1 |
Handke, R; Peleg, AY; Slavin, M; Szer, J; Tong, SY; Yoong, J | 1 |
Bertilsson, L; Hynninen, VV; Kurkinen, K; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
Chen, SC; Sorrell, TC | 1 |
Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W | 1 |
Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A | 1 |
Nailor, MD; Revankar, SG; Sobel, JD | 1 |
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL | 1 |
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I | 1 |
Agee, S; Ford, JG; Greenhaw, ST | 1 |
Ghannoum, MA; Mukherjee, PK; Shehata, AS | 1 |
Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK; Revankar, SG | 1 |
Brown, TA; Grooters, AM; Hosgood, GL | 1 |
Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC | 1 |
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
Li, R; Liu, W; Wan, Z; Wang, X; Yang, J | 1 |
Almeida, LM; Bianchin, DB; Souza, EA; Svidzinski, TI | 1 |
Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M | 1 |
Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
López-Martínez, R | 1 |
Cos, P; de Wit, K; Maes, L; Matheeussen, A; Paulussen, C; van Rossem, K | 1 |
Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH | 1 |
Alvarez, E; Cano, JF; Dromer, F; Fothergill, AW; Garcia-Hermoso, D; Guarro, J; Hoinard, D; Rinaldi, MG; Stchigel, AM; Sutton, DA | 1 |
Fahal, AH; van Belkum, A; van de Sande, WW | 1 |
Blanche, S; Bougnoux, ME; Catherinot, E; Coignard, H; Debourgogne, A; Garcia-Hermoso, D; Hassouni, N; Lecuit, M; Lortholary, O; Machouart, M; Rivier, A; Salmon, A | 1 |
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
Biancalana, FS; Lyra, L; Schreiber, AZ | 1 |
Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
Ashton, S; Elewski, B; Pollak, R; Rich, P; Schlessinger, J; Tavakkol, A | 1 |
Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J | 1 |
Goel, RS; Gupta, A; Jain, A; Kataria, R; Singh, S; Sinha, VD | 1 |
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
Chen, J; Liang, L; Liu, D | 1 |
Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y | 1 |
Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y | 1 |
Cano, J; Colombo, AL; Gonçalves, SS; Guarro, J; Stchigel, AM | 1 |
Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M | 1 |
Arima, N; Iida, J; Inano, S; Kimura, M | 1 |
Li, R; Yu, J; Zhang, S | 1 |
Fernandez Miralbell, A; Garcia Mellado, V; Martin Castro, A; Martinez Peinado, C; Nogueras Morillas, P; Soto Diaz, A; Tercedor Sanchez, J; Valenzuela Salas, I | 1 |
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D | 1 |
Lipner, S; Scher, RK | 1 |
Fahal, AH; Nenoff, P; Reinel, D; Schöfer, H; van de Sande, WW | 1 |
Ikeda, F; Iyoda, T; Mikawa, T; Suzuki, M; Yamaguchi, H | 1 |
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
Canavan, T; Cantrell, W; Elewski, B | 1 |
Li, R; Wan, Z; Yao, L; Yu, J | 1 |
Cohen, J; Joyce, C; Mikailov, A; Mostaghimi, A | 1 |
Hossin, B; Murdan, S; Rizi, K | 1 |
Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Toga, T; Tsuboi, R | 1 |
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
Rosen, T; Stein Gold, LF | 2 |
Chanda, S; Coronado, D; Del Rosso, J; Zane, LT | 1 |
Andrade, ZM; Correia, MD; Dalbem, PT; de Oliveira Alves, K; de Oliveira, CF; Heidrich, D; Landell, MF; Pagani, DM; Paulino, GV; Scroferneker, ML; Silva, C; Valente, P | 1 |
Hiruma, M; Ihn, H; Kano, R; Matsumoto, T; Noguchi, H | 1 |
Arendrup, MC; Frandsen, TL; Jensen, TSR; Juhler, M; Nygaard, U; von Buchvald, C | 1 |
Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
Chen, C; Han, HS; Kano, R; Noli, C | 1 |
Almeida-Paes, R; Brito-Santos, F; Figueiredo-Carvalho, MHG; Gutierrez-Galhardo, MC; Machado, ACS; Oliveira, MME; Pereira, SA; Zancopé-Oliveira, RM | 1 |
Bianco, D; Stewart, J | 1 |
Lipner, SR; Scher, RK | 1 |
Baltazar, LM; Costa-Orlandi, CB; Friedman, AJ; Friedman, JM; Mendes-Giannini, MJS; Mordorski, B; Nosanchuk, JD | 1 |
Fukushima, S; Hirose, M; Hiruma, M; Ihn, H; Matsumoto, T; Noguchi, H; Yaguchi, T | 1 |
Ai, M; Han, J; He, B; Hu, Z; Li, G; Ma, L; Niu, Y; Sun, Y; Zeng, B | 1 |
Alastruey-Izquierdo, A; de Hoog, S; Kurzai, O; Voigt, K; Wagner, L; Walther, G | 1 |
Fukushima, S; Hiruma, M; Ihn, H; Kano, R; Kimura, U; Matsumoto, T; Noguchi, H; Yaguchi, T | 1 |
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
Harada, K; Hase, M; Hiruma, J; Hiruma, M; Kamata, H; Kano, R; Noguchi, H; Yokota, M | 1 |
Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
Balfour-Lynn, IM; Bentley, S; Carr, SB; Davies, JC | 1 |
Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
Geizhals, S; Lipner, SR | 1 |
Aoi, J; Fukushima, S; Kashiwada-Nakamura, K; Kubo, M; Makino, K; Noguchi, H | 1 |
Abramovits, W; Guenin, EP; Gupta, AK; Venkataraman, M | 1 |
Guillot, J; Rezaei-Matehkolaei, A; Shamsizadeh, F; Shariat Nabavi, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
Hiruma, M; Kano, R; Kimura, U; Kubo, M; Matsumoto, T; Noguchi, H; Tanaka, M; Yaguchi, T; Yamada, T | 1 |
Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
15 review(s) available for triazoles and terbinafine
Article | Year |
---|---|
[Antifungal agents--recent trends in development and progress in research of action mechanism].
Topics: Administration, Oral; Animals; Antifungal Agents; Benzylamines; Humans; Imidazoles; Injections; Naphthalenes; Terbinafine; Triazoles | 1991 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
Newer systemic antifungal drugs for the treatment of onychomycosis.
Topics: Aged; Antifungal Agents; Child; Enzyme Inhibitors; Female; Griseofulvin; HIV Infections; Humans; Imidazoles; Male; Naphthalenes; Onychomycosis; Terbinafine; Triazoles | 1996 |
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Terbinafine; Triazoles | 2005 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Use of terbinafine in rare and refractory mycoses.
Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Drug Resistance, Fungal; Humans; Mycoses; Naphthalenes; Terbinafine; Treatment Outcome; Triazoles | 2008 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Candidosis, a new challenge.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Echinocandins; Humans; Imidazoles; Naphthalenes; Nystatin; Terbinafine; Triazoles | 2010 |
Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Fusariosis; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2013 |
Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
Topics: Actinomycetales; Actinomycetales Infections; Amputation, Surgical; Animals; Anti-Bacterial Agents; Antifungal Agents; Cytokines; Debridement; Diagnosis, Differential; Humans; Inflammation; Itraconazole; Madurella; Mycetoma; Naphthalenes; Terbinafine; Triazoles | 2015 |
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2016 |
Ungual hyalohyphomycosis caused by Fusarium proliferatum in an immunocompetent patient.
Topics: Administration, Topical; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Fusarium; Humans; Hyphae; Naphthalenes; Onychomycosis; Terbinafine; Triazoles | 2017 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
A Timeline of Onychomycosis Therapy and Future Directions.
Topics: Administration, Topical; Antifungal Agents; Humans; Itraconazole; Nail Diseases; Onychomycosis; Terbinafine; Triazoles | 2020 |
4 trial(s) available for triazoles and terbinafine
Article | Year |
---|---|
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Topics: Administration, Oral; Adult; Alfentanil; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Color Vision Defects; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Naphthalenes; Photophobia; Pyrimidines; Sex Factors; Terbinafine; Triazoles; Vomiting; Voriconazole | 2006 |
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dealkylation; Desvenlafaxine Succinate; Drug Interactions; Enzyme Inhibitors; Genotype; Half-Life; Humans; Male; Naphthalenes; Phenotype; Polymorphism, Genetic; Pyrimidines; Reference Values; Terbinafine; Triazoles; Venlafaxine Hydrochloride; Voriconazole | 2008 |
A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Male; Middle Aged; Naphthalenes; Onychomycosis; Tablets; Terbinafine; Treatment Outcome; Triazoles; Young Adult | 2012 |
Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.
Topics: Administration, Oral; Administration, Topical; Algorithms; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Health Care Costs; Humans; Hydroxides; Naphthalenes; Onychomycosis; Periodic Acid-Schiff Reaction; Potassium Compounds; Potentially Inappropriate Medication List; Terbinafine; Triazoles | 2016 |
103 other study(ies) available for triazoles and terbinafine
Article | Year |
---|---|
Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
Topics: Animals; Cell Division; Chromatography, Gas; Chromatography, Thin Layer; Ergosterol; Naphthalenes; Terbinafine; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 1991 |
Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.
Topics: Animals; Ergosterol; Ketoconazole; Naphthalenes; Terbinafine; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells | 1991 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole; Mice; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 1988 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
Topics: Antifungal Agents; Candida albicans; Depression, Chemical; Drug Resistance, Microbial; Ergosterol; Ketoconazole; Morpholines; Naphthalenes; Terbinafine; Triazoles | 1994 |
Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.
Topics: Animals; Antifungal Agents; Chagas Disease; Disease Models, Animal; Ergosterol; Female; Ketoconazole; Mice; Naphthalenes; Terbinafine; Triazoles; Trypanocidal Agents | 1993 |
Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
Topics: Animals; Antifungal Agents; Azoles; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Resistance; Enzyme Inhibitors; Ketoconazole; Leishmania braziliensis; Leishmania mexicana; Naphthalenes; Oxidoreductases; Squalene; Sterol 14-Demethylase; Sterols; Terbinafine; Triazoles | 1996 |
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Male; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis; Triazoles; Trichophyton | 2002 |
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
Topics: Antifungal Agents; Drug Interactions; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2003 |
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Topics: Aged; Ankle Injuries; Antifungal Agents; Debridement; Drug Synergism; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole | 2004 |
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles | 2004 |
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
Topics: Animals; Antifungal Agents; Dermatologic Agents; Guinea Pigs; Imidazoles; Itraconazole; Mice; Mitosporic Fungi; Mycoses; Naphthalenes; Stereoisomerism; Structure-Activity Relationship; Terbinafine; Triazoles | 2005 |
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2005 |
[Synthesis and antifungal activity of novel triazole antifungal agents].
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Structure-Activity Relationship; Terbinafine; Triazoles | 2004 |
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
Topics: Antifungal Agents; Child; Female; Fungemia; Humans; Immunocompromised Host; Mycetoma; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2005 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Mitomycin; Mycetoma; Naphthalenes; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Terbinafine; Triazoles; Voriconazole | 2005 |
[Physiological comportment and in vivo sensitivity of Sporothrix schenckii isolates maintained for 18 years by two preservation methods].
Topics: Agar; Antifungal Agents; Drug Resistance, Fungal; Glucose; Itraconazole; Microbial Sensitivity Tests; Mycology; Naphthalenes; Potassium Iodide; Preservation, Biological; Sporothrix; Starch; Terbinafine; Time Factors; Triazoles; Water | 2005 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine.
Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Drug Resistance, Fungal; Granulomatous Disease, Chronic; Humans; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2007 |
Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Debridement; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Mycetoma; Naphthalenes; Osteomyelitis; Pyrimidines; Scedosporium; Terbinafine; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Topics: Antifungal Agents; Drug Synergism; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Stem Cell Transplantation; Terbinafine; Triazoles; Voriconazole | 2007 |
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole | 2008 |
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole | 2009 |
Successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Middle Aged; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Microbial Viability; Mycology; Naphthalenes; Pyridones; Pyrimidines; Sensitivity and Specificity; Spectrophotometry; Terbinafine; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole | 2008 |
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Soft Tissue Infections; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2009 |
In vitro response of cutaneous mycosis fungal agents to the most widely used systemic antifungals in dermatology.
Topics: Antifungal Agents; Dermatomycoses; Humans; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Triazoles | 2009 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2010 |
In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.
Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Dermatitis; Female; Guinea Pigs; Humans; Imidazoles; Inhibitory Concentration 50; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Triazoles; Vaginitis | 2010 |
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2010 |
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Environmental Microbiology; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Naphthalenes; Peptide Elongation Factor 1; Phylogeny; Sequence Analysis, DNA; Spores, Fungal; Temperature; Terbinafine; Triazoles | 2010 |
In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Triazoles | 2011 |
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.
Topics: Abscess; Adolescent; Adult; Antifungal Agents; Azoles; Caspofungin; Chemoprevention; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Eurotiales; Fatal Outcome; Female; Granulomatous Disease, Chronic; Histocytochemistry; Humans; Interferon-gamma; Lipopeptides; Male; Microscopy; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Craniocerebral maduromycosis.
Topics: Adolescent; Antifungal Agents; Bone Diseases; Brain Diseases; Female; Humans; India; Madurella; Magnetic Resonance Imaging; Mycetoma; Naphthalenes; Parietal Lobe; Pyrimidines; Scalp; Seizures; Terbinafine; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole | 2013 |
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon | 2013 |
In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Echinocandins; Microbial Sensitivity Tests; Naphthalenes; Phylogeny; Terbinafine; Triazoles | 2013 |
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles | 2012 |
Drug combinations against Mucor irregularis in vitro.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles | 2013 |
Skin infection caused by Scedosporium apiospermum in immunocompromised patients. Report of two cases.
Topics: Abscess; Aged; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole | 2013 |
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2014 |
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2014 |
[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Itraconazole; Naphthalenes; Terbinafine; Thiazoles; Triazoles | 2014 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
Topics: Administration, Topical; Aged; Antifungal Agents; Foot Dermatoses; Humans; Male; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Treatment Outcome; Triazoles | 2015 |
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Scopulariopsis; Terbinafine; Triazoles | 2015 |
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult | 2016 |
[In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
Topics: Allylamine; Antifungal Agents; Drug Resistance, Fungal; Imidazoles; Microbial Sensitivity Tests; Naphthalenes; Pyridines; Terbinafine; Thiocarbamates; Triazoles; Trichophyton | 2016 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Introduction.
Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Foot Dermatoses; Humans; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles | 2016 |
Susceptibility to antifungal agents and enzymatic activity of Candida haemulonii and Cutaneotrichosporon dermatis isolated from soft corals on the Brazilian reefs.
Topics: Animals; Anthozoa; Antifungal Agents; Basidiomycota; Brazil; Candida; DNA, Ribosomal; Drug Resistance, Multiple, Fungal; Esterases; Fluconazole; Gelatinases; Humans; Imidazoles; Microbial Sensitivity Tests; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2016 |
Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.
Topics: Amphotericin B; Antifungal Agents; Brain; Child, Preschool; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Naphthalenes; Nose; Opportunistic Infections; Orbit; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Terbinafine; Triazoles | 2017 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; Ketoconazole; Malaysia; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2017 |
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Terbinafine; Triazoles | 2017 |
Treatment of refractory sino-nasal aspergillosis with posaconazole and terbinafine in 10 dogs.
Topics: Animals; Antifungal Agents; Aspergillosis; Dog Diseases; Dogs; Naphthalenes; Prospective Studies; Terbinafine; Treatment Outcome; Triazoles | 2017 |
Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments.
Topics: Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Nanoparticles; Naphthalenes; Nitric Oxide; Onychomycosis; Permeability; Prescription Fees; Terbinafine; Treatment Outcome; Triazoles; Trichophyton | 2018 |
Onychomycosis caused by Aspergillus subramanianii.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Female; Foot Dermatoses; Humans; Hyphae; Japan; Microscopy; Onychomycosis; Terbinafine; Triazoles; Young Adult | 2018 |
Gene transcription profiling of Aspergillus oryzae 3.042 treated with ergosterol biosynthesis inhibitors.
Topics: Aspergillus oryzae; Ergosterol; Fungal Proteins; Fungicides, Industrial; Gene Expression Profiling; Gene Expression Regulation, Fungal; Terbinafine; Transcription, Genetic; Triazoles | 2019 |
A Revised Species Concept for Opportunistic
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucormycosis; Natamycin; Nitriles; Pyridines; Rhizopus; Species Specificity; Terbinafine; Triazoles | 2019 |
Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole.
Topics: Aged; Antifungal Agents; Drug Resistance, Fungal; Female; Hand Dermatoses; Humans; Onychomycosis; Terbinafine; Thiazoles; Tinea; Triazoles | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Thiazoles; Triazoles | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Combination antifungal therapy for Scedosporium species in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Ascomycota; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Triazoles | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium.
Topics: Administration, Topical; Antifungal Agents; Humans; Onychomycosis; Terbinafine; Triazoles | 2021 |
JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Child; Foot Dermatoses; Humans; Onychomycosis; Terbinafine; Triazoles | 2021 |
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Triazoles | 2022 |
Effective Response of Dermatophytoma Caused by Terbinafine-Resistant Trichophyton interdigitale Solely to Topical Efinaconazole.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Microbial Sensitivity Tests; Terbinafine; Triazoles; Trichophyton | 2022 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |